| 前收市價 | 163.56 |
| 開市 | 164.13 |
| 買盤 | 157.00 x 900 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 163.88 - 166.02 |
| 52 週波幅 | 71.51 - 166.02 |
| 成交量 | |
| 平均成交量 | 791,935 |
| 市值 | 13.859B |
| Beta 值 (5 年，每月) | 0.86 |
| 市盈率 (最近 12 個月) | 17.57 |
| 每股盈利 (最近 12 個月) | 9.40 |
| 業績公佈日 | 2024年11月05日 - 2024年11月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 155.86 |
ZacksARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan
The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.
ZacksZacks Investment Ideas feature highlights: Intuitive Surgical, SharkNinja and DaVita
Intuitive Surgical, SharkNinja and DaVita have been highlighted in this Investment Ideas article.
Insider MonkeyGoldman Thinks DaVita Inc. (DVA) Is A Long-Term AI Stock Set To Rally Eventually
We recently published a list of Beyond the Tech Giants: 35 Non-Tech AI Opportunities. In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against the other not-tech AI stocks. Investors have been desperately searching for a safer way to play the AI boom that has swept the US stock […]
